QQQ   444.67 (-0.04%)
AAPL   170.86 (-1.41%)
MSFT   421.53 (+0.02%)
META   489.96 (-0.79%)
GOOGL   150.73 (-0.09%)
AMZN   181.07 (+0.69%)
TSLA   177.62 (-1.23%)
NVDA   907.51 (+0.56%)
NIO   4.60 (-1.50%)
AMD   181.89 (+1.28%)
BABA   72.45 (+1.20%)
T   17.57 (+0.11%)
F   13.21 (+1.15%)
MU   118.60 (-0.45%)
CGC   9.27 (-2.93%)
GE   174.72 (-3.00%)
DIS   122.63 (+1.36%)
AMC   3.77 (-13.13%)
PFE   27.91 (+0.47%)
PYPL   66.85 (+0.42%)
XOM   115.41 (+0.38%)
QQQ   444.67 (-0.04%)
AAPL   170.86 (-1.41%)
MSFT   421.53 (+0.02%)
META   489.96 (-0.79%)
GOOGL   150.73 (-0.09%)
AMZN   181.07 (+0.69%)
TSLA   177.62 (-1.23%)
NVDA   907.51 (+0.56%)
NIO   4.60 (-1.50%)
AMD   181.89 (+1.28%)
BABA   72.45 (+1.20%)
T   17.57 (+0.11%)
F   13.21 (+1.15%)
MU   118.60 (-0.45%)
CGC   9.27 (-2.93%)
GE   174.72 (-3.00%)
DIS   122.63 (+1.36%)
AMC   3.77 (-13.13%)
PFE   27.91 (+0.47%)
PYPL   66.85 (+0.42%)
XOM   115.41 (+0.38%)
QQQ   444.67 (-0.04%)
AAPL   170.86 (-1.41%)
MSFT   421.53 (+0.02%)
META   489.96 (-0.79%)
GOOGL   150.73 (-0.09%)
AMZN   181.07 (+0.69%)
TSLA   177.62 (-1.23%)
NVDA   907.51 (+0.56%)
NIO   4.60 (-1.50%)
AMD   181.89 (+1.28%)
BABA   72.45 (+1.20%)
T   17.57 (+0.11%)
F   13.21 (+1.15%)
MU   118.60 (-0.45%)
CGC   9.27 (-2.93%)
GE   174.72 (-3.00%)
DIS   122.63 (+1.36%)
AMC   3.77 (-13.13%)
PFE   27.91 (+0.47%)
PYPL   66.85 (+0.42%)
XOM   115.41 (+0.38%)
QQQ   444.67 (-0.04%)
AAPL   170.86 (-1.41%)
MSFT   421.53 (+0.02%)
META   489.96 (-0.79%)
GOOGL   150.73 (-0.09%)
AMZN   181.07 (+0.69%)
TSLA   177.62 (-1.23%)
NVDA   907.51 (+0.56%)
NIO   4.60 (-1.50%)
AMD   181.89 (+1.28%)
BABA   72.45 (+1.20%)
T   17.57 (+0.11%)
F   13.21 (+1.15%)
MU   118.60 (-0.45%)
CGC   9.27 (-2.93%)
GE   174.72 (-3.00%)
DIS   122.63 (+1.36%)
AMC   3.77 (-13.13%)
PFE   27.91 (+0.47%)
PYPL   66.85 (+0.42%)
XOM   115.41 (+0.38%)

iRhythm Technologies (IRTC) Stock Price, News & Analysis

$116.01
+0.25 (+0.22%)
(As of 11:14 AM ET)
Today's Range
$113.27
$116.66
50-Day Range
$102.09
$123.61
52-Week Range
$70.24
$140.23
Volume
46,767 shs
Average Volume
419,684 shs
Market Capitalization
$3.59 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$135.11

iRhythm Technologies MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
16.7% Upside
$135.11 Price Target
Short Interest
Bearish
7.97% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.10mentions of iRhythm Technologies in the last 14 days
Based on 16 Articles This Week
Insider Trading
Selling Shares
$5.02 M Sold Last Quarter
Proj. Earnings Growth
Growing
From ($3.14) to ($1.98) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.62 out of 5 stars

Medical Sector

870th out of 939 stocks

Surgical & Medical Instruments Industry

93rd out of 99 stocks

IRTC stock logo

About iRhythm Technologies Stock (NASDAQ:IRTC)

iRhythm Technologies, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. The company also provides the Zio Monitor System, a prescription-only, remote electrocardiogram (ECG) monitoring system that consists of a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period, including specific arrhythmia events detected by the ZEUS System; the Zio XT System is the previous generation of the Zio Monitor System and is a prescription-only, remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and the Zio AT system, a prescription-only, remote ECG monitoring system that similarly consists of the Zio AT patch that records the electric signal from the heart continuously for up to 14 days and the ZEUS System, but which also incorporates the Zio AT wireless gateway that provides connectivity between the Zio AT patch and the ZEUS System during the patient wear period. It has a development collaboration agreement with Verily Life Sciences LLC and Verity Ireland Limited to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.

IRTC Stock Price History

IRTC Stock News Headlines

Altcoin FRENZY Alert…
Bitcoin recently crossed the highest price in its 15-year history… Less than 2 years after one of the most vicious crypto market meltdowns we've ever seen! Bitcoin's BOOM also sent shockwaves through the altcoin market, with select coins seeing HUGE moves in a matter of days… Like Fetch.ai, that gained over 350% in just the last 30 days…
The AI Defense Stock Set to Soar
To protect our interests, The Pentagon has partnered with this small AI defense contractor - creating some of the most powerful AI defenses ever made.
IRTC Quantitative Stock Analysis
IRTC Jan 2025 130.000 call
IRTC Jan 2025 80.000 put
IRTC Apr 2024 160.000 call
See More Headlines
Receive IRTC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for iRhythm Technologies and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/22/2024
Today
3/28/2024
Next Earnings (Estimated)
5/02/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:IRTC
Fax
N/A
Employees
2,000
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$135.11
High Stock Price Target
$165.00
Low Stock Price Target
$110.00
Potential Upside/Downside
+16.6%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
8 Analysts

Profitability

Net Income
$-123,410,000.00
Pretax Margin
-24.90%

Debt

Sales & Book Value

Annual Sales
$492.68 million
Book Value
$6.85 per share

Miscellaneous

Free Float
30,846,000
Market Cap
$3.59 billion
Optionable
Optionable
Beta
1.30
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

IRTC Stock Analysis - Frequently Asked Questions

Should I buy or sell iRhythm Technologies stock right now?

8 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for iRhythm Technologies in the last twelve months. There are currently 8 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" IRTC shares.
View IRTC analyst ratings
or view top-rated stocks.

What is iRhythm Technologies' stock price target for 2024?

8 analysts have issued 1 year price targets for iRhythm Technologies' stock. Their IRTC share price targets range from $110.00 to $165.00. On average, they predict the company's stock price to reach $135.11 in the next twelve months. This suggests a possible upside of 16.7% from the stock's current price.
View analysts price targets for IRTC
or view top-rated stocks among Wall Street analysts.

How have IRTC shares performed in 2024?

iRhythm Technologies' stock was trading at $107.04 at the beginning of 2024. Since then, IRTC stock has increased by 8.1% and is now trading at $115.76.
View the best growth stocks for 2024 here
.

Are investors shorting iRhythm Technologies?

iRhythm Technologies saw a increase in short interest during the month of March. As of March 15th, there was short interest totaling 2,470,000 shares, an increase of 37.2% from the February 29th total of 1,800,000 shares. Based on an average daily trading volume, of 408,100 shares, the short-interest ratio is currently 6.1 days.
View iRhythm Technologies' Short Interest
.

When is iRhythm Technologies' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 2nd 2024.
View our IRTC earnings forecast
.

How were iRhythm Technologies' earnings last quarter?

iRhythm Technologies, Inc. (NASDAQ:IRTC) issued its earnings results on Thursday, February, 22nd. The company reported ($1.26) EPS for the quarter, missing analysts' consensus estimates of ($0.60) by $0.66. The firm had revenue of $132.51 million for the quarter, compared to analysts' expectations of $131.14 million. iRhythm Technologies had a negative net margin of 25.05% and a negative trailing twelve-month return on equity of 56.38%.

What guidance has iRhythm Technologies issued on next quarter's earnings?

iRhythm Technologies issued an update on its FY 2024 earnings guidance on Tuesday, February, 27th. The company provided EPS guidance of for the period. The company issued revenue guidance of $575.0 million-$585.0 million, compared to the consensus revenue estimate of $581.1 million.

What is Kevin M. King's approval rating as iRhythm Technologies' CEO?

20 employees have rated iRhythm Technologies Chief Executive Officer Kevin M. King on Glassdoor.com. Kevin M. King has an approval rating of 91% among the company's employees. This puts Kevin M. King in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of iRhythm Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other iRhythm Technologies investors own include NVIDIA (NVDA), Alibaba Group (BABA), Salesforce (CRM), Block (SQ), Teladoc Health (TDOC), Trade Desk (TTD), Advanced Micro Devices (AMD), Intel (INTC), Broadcom (AVGO) and Boeing (BA).

When did iRhythm Technologies IPO?

iRhythm Technologies (IRTC) raised $76 million in an initial public offering on Thursday, October 20th 2016. The company issued 5,400,000 shares at $13.00-$15.00 per share. J.P. Morgan and Morgan Stanley acted as the underwriters for the IPO and Canaccord Genuity and BTIG were co-managers.

Who are iRhythm Technologies' major shareholders?

iRhythm Technologies' stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (9.77%), Vanguard Group Inc. (9.66%), Capital Research Global Investors (8.14%), Sands Capital Management LLC (7.30%), Artisan Partners Limited Partnership (6.76%) and Mackenzie Financial Corp (4.13%). Insiders that own company stock include Daniel G Wilson, David A Vort, Douglas Devine, Kevin M King, Mark J Day, Merz Cathleen Noel Bairey, Patrick Michael Murphy and Quentin S Blackford.
View institutional ownership trends
.

How do I buy shares of iRhythm Technologies?

Shares of IRTC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:IRTC) was last updated on 3/28/2024 by MarketBeat.com Staff

From Our Partners